Roche/Genentech

Eylea erodes Lucentis, Avastin market share
Medical Marketing and Media
Tue, 08/4/15 - 06:10 pm
Eylea
Lucentis
Avastin
Regeneron
Roche/Genentech
Study: Herceptin plus Tykerb helps women with early breast cancer more than either drug alone
Yahoo/AP
Fri, 12/10/10 - 10:04 am
breast cancer
Herceptin
Tykerb
GSK
Roche/Genentech
Phase III Study Showed Rituxan® for Initial Use Followed by Continued Use Delayed the Need for Additional Therapy in People with Asymptomatic Follicular Lymphoma, a Common Type of Blood Cancer
Yahoo/BusinessWire
Sun, 12/5/10 - 11:43 am
Rituxan
follicular lymphoma
Roche/Genentech
Biogen Idec
Gene Therapy Takes a Turn for the Better
Businessweek
Fri, 04/23/10 - 11:25 am
gene therapy
Genzyme
Roche/Genentech
Genetix
Immunogen's Busy Month, Part I
Seeking Alpha
Tue, 12/1/09 - 09:51 am
Immunogen
GSK
Sanofi
Roche/Genentech